We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App





Samsung’s Latest Best-in-Class Technologies Take Center Stage at RSNA 2022

By MedImaging International staff writers
Posted on 25 Nov 2022
Print article
Image: Samsung is highlighting its innovations in ultrasound, DR and mobile CT at RSNA 2022 (Photo courtesy of Samsung)
Image: Samsung is highlighting its innovations in ultrasound, DR and mobile CT at RSNA 2022 (Photo courtesy of Samsung)

Samsung Electronics (Suwon-si, South Korea) is unveiling its latest artificial intelligence (AI) technologies and presenting its premium diagnostic solutions in ultrasound, digital radiography (DR) and mobile computed tomography (CT) at the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting from November 27 to December 1.

At RSNA 2022, Samsung is highlighting its achievements this year that empower clinicians to diagnose their patients more confidently. At the event, Samsung is showcasing its leading product updates, including the V7 ultrasound system, a new endocavity transducer and new real-time on-device AI solutions. The new on-device AI solution for ultrasound, known as HeartAssist, which can enhance the diagnosis and examination process, is on display. This deep learning-based function automatically finds the cross-section of the heart and measures different points needed for an accurate diagnosis. The automated nature allows for a streamlined workflow due to fewer keystrokes. The feature can be found on Samsung’s V8 and V7 ultrasound systems. The miniER7, a new endocavity transducer, is being shown alongside the V7 ultrasound system. With a radius size of 7mm — 3mm smaller than the existing probe — the new probe has been designed to ease the burden felt by healthcare professionals as well as the discomfort that patients often experience during prostate ultrasound scanning. The miniER7 has been created with state-of-the-art micro-processing technology to capture clear images at a reduced file size.

Samsung is also showcasing its premium digital radiography solutions, including the new “Vision Assist” solution and AccE Glass Free Detector. The AccE GC85A Vision2 premium ceiling digital radiography system with “Vision Assist” provides more enhanced patient care and workflow efficiency maintaining an advanced low-dose imaging experience. Samsung also recently released a new flagship detector, the AccE Glass-Free Detector, which offers a more comfortable imaging experience without compromising image quality.

Samsung is also showcasing the OmniTom Elite with Photon Counting Detector (PCD) technology and BodyTom 64. The state-of-the-art OmniTom Elite has the ability to provide versatile, real-time mobile imaging to administer point-of-care CT to critical patients without the need to transport them to a separate imaging department. With the addition of PCD technology, the system provides the ability to capture CT data in multiple energy bands. The BodyTom 64 is an upgraded version of the BodyTom Elite CT scanner, providing enhanced functionality with high-resolution imaging capabilities. The head-to-toe trauma imaging solution boasts revisions based on customer feedback, with indications for both pediatric and adult imaging and can be used for low dose lung cancer screening. The BodyTom 64 is a multi-departmental imaging solution that can be utilized in neurosurgery, interventional radiology, brachytherapy, trauma, medical examination and more.

“Samsung has a long-standing history of leading the charge in technology advancements – 2022 has been a testament to this as we have worked to redefine our cutting-edge solutions across modalities. We’re now deploying real-time on-device AI technology to help healthcare professionals examine and diagnose patients with ease and accuracy from the start,” said David Legg, Vice President, Head of Business, Boston Imaging, a subsidiary of Samsung.

“Innovation is at the core of Samsung’s business. We take great pride in delivering our customers’ leading-edge technology on all Samsung devices,” said Kyu Tae Yoo, Senior Vice President, Global Head of Sales and Marketing, Samsung Medison. “As we look to expand diagnostic possibilities and improve the clinical experience that our customers need, we will keep healthcare professionals and the patients they treat top of mind.”

Related Links:
Samsung Electronics

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Ultrasound Doppler System
Doppler BT-200
New
Thyroid Shield
Standard Thyroid Shield

Print article
Radcal

Channels

Radiography

view channel
Image: LumiGuide enables doctors to navigate through blood vessels using light instead of X-ray (Photo courtesy of Philips)

3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery

In vascular surgery, doctors frequently employ endovascular surgery techniques using tools such as guidewires and catheters, often accessing through arteries like the femoral artery. This method is known... Read more

MRI

view channel
Image: The VR visualization platform provides patients and surgeons with access to real-time 3D medical imaging (Photo courtesy of Avatar Medical)

VR Visualization Platform Creates 3D Patient Avatars from CT and MR Images in Real-Time

Surgeons and patients must currently rely on black and white medical images interpreted by radiologists. This limitation becomes more pronounced in complex surgeries, leading to issues such as patient... Read more

Ultrasound

view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: Routine chest CT holds untapped potential for revealing patients at risk for cardiovascular disease (Photo courtesy of Johns Hopkins)

Routine Chest CT Exams Can Identify Patients at Risk for Cardiovascular Disease

Coronary artery disease (CAD) is the primary cause of death globally. Adults without symptoms but at risk can be screened using EKG-gated coronary artery calcium (CAC) CT scans, which are crucial in assessing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.